Professor Judy Bradley is currently the SRO/CEO iREACH Health. She is Director of the Wellcome Trust-Wolfson Northern Ireland Clinical Research Facility & is also a Co-lead Northern Ireland Clinical Research Network (Respiratory Health)

Prior to this, Professor Bradley held a joint appointment in Physiotherapy between Ulster University and Belfast Health and Social Care Trust. She completed her degree B.Sc. in Physiotherapy in Ulster University in 1994 after which she worked as a Physiotherapist within the UK. In 1999 she completed her PhD which focused on the development and testing of a field exercise test for CF.

In 1998 she was appointed as Lecturer Practitioner/Reader in Physiotherapy, between Ulster University and Regional Adult CF Centre, until 2012 when she was appointed as Professor in Physiotherapy at Ulster University. She joined Queen's University Belfast in July 2015 when appointed as Director of the Northern Ireland Clinical Research Facility. In March 2022 Professor Bradley was appointed SRO/CEO of iREACH Health which is One of the innovation projects within the BRCD.  iREACH Health will build a wider healthcare ecosystem to support the development of new treatments that will be rapidly assessed in early phase R&D programmes. This will allow the Belfast region to leverage additional industrial investment and funding for R&D, attract and retain skilled individuals to ensure sustainability in the Life and Health Science (LHS) sector, drive economic growth and ultimately deliver better treatments to patients in NI.

Professor Bradley is currently lead applicant on a NIHR grant, in excess of £1million, evaluating the efficacy of mucolytic therapies in bronchiectasis and leads this trial within up to twenty sites across the UK.

Professor Bradely is a Co-investigators on the study iREHAB from January 2022 Remote multicomponent rehabilitation compared to standard care for survivors of critical illness after hospital discharge: a randomised controlled assessor-blind clinical and cost-effectiveness trial with internal pilot.

Professor Bradley’s research programme is focused on respiratory health. She is involved in several programmes exploring the effectiveness of therapies linked to optimising airway clearance via pharmacological and non-pharmacological approaches as well as rehabilitation and adherence interventions. These programmes are funded for example by MRC, NIHR and are multi-centre and employ a wide range of trial designs (RCT, observational) and methodologies (both quantitative and qualitative methods).

PROFESSIONAL MEMBERSHIP

1994 - Present - Member Chartered Society of Physiotherapy 

1994 – Present - Member Health Professions Council 

1999 – Present - Member Association Chartered Physiotherapists in CF

2003 – Present - Member Association Chartered Physiotherapists in Respiratory Care

2012 - Present - Member of the European Respiratory Society

2012 - Present- Member of the European Cystic Fibrosis Society

2022 - Present ExACT-CF TSC Steer Group

2022 - Present CFSTORM Trial Management Group

2019 - Present NTM Network UK Steering Group